Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2025-12-24 @ 6:32 PM
NCT ID:
NCT05184257
Eligibility Criteria:
Inclusion Criteria
* Diagnosed with primary breast cancer
* Female, ≥18 years old (at index date)
* HR positive
* Receive Zoladex® 10.8 mg or Zoladex® 3.6 mg treatment
* Premenopausal status prior to the treatment of Zoladex®. Baseline premenopausal status will be confirmed if the patient's last E2 measurement within 180 days prior to the index date indicated premenopausal status or there was a recorded menstrual history within 180 days prior to the index date
* At least one actual or expected E2 testing measurement within 8-28 weeks of the index date Exclusion Criteria
* Patients received concurrent treatments that may affect E2 testing results
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT05184257
Study Brief:
Protocol Section:
NCT05184257